drugset / Trial / NCT05369468

Dexmetomidine With Erector Spinae Plane Block in Cholecystectomy

NCT05369468

Phase 1/2 Completed 60 enrolled Tanta University
RandomizedParallel-groupDouble-blindSupportive care

Summary

Sixty patients scheduled for elective laparoscopic cholecystectomy will be randomly assigned using sealed envelope into two equal groups (30 patients each). Group 1: will receive bilateral ESP block with injection of 20 ml of 0.25% Bupivacaine in each site of injection . Group 2: will receive bilateral ESP block with injection of 18ml of 0.25% Bupivacaine plus 2ml dexmedetomidine 0.5 ug /kg in each site of injection .

Timeline

Start
2020-01-22
Primary completion
2022-11-10
Completion
2022-11-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified 18 ml Other
Comparator Bupivacaine Other / unclassified 20 ml Other
Subject Dexmedetomidine Other / unclassified 0.5 ug/kg Other

Indications

No indication recorded.